Literature DB >> 16151042

Reactive astrocytes in neural repair and protection.

Michael V Sofroniew1.   

Abstract

Reactive astrocytosis occurs prominently in response to all forms of CNS injury or disease. The functions of reactive astrocytes are not well understood, and both harmful and beneficial activities have been attributed to these cells. The basic process of reactive astrocytosis is conserved in vertebrate evolution, suggesting fitness-enhancing benefits, but scar-forming reactive astrocytes are often regarded as uniformly detrimental to clinical outcome, in particular, when implicated as inhibitors of axon regeneration. Transgenic mouse models are providing new means to study the activities of reactive astrocytes after CNS insults in vivo. Recent studies point toward roles for reactive astrocytes in restricting inflammation and protecting neurons and oligodendrocytes, thereby helping to limit tissue degeneration and preserve function after CNS injury.

Entities:  

Mesh:

Year:  2005        PMID: 16151042     DOI: 10.1177/1073858405278321

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  290 in total

1.  Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury.

Authors:  Juan Pablo de Rivero Vaccari; Julia Minkiewicz; Xiaoliang Wang; Juan Carlos De Rivero Vaccari; Ramon German; Alex E Marcillo; W Dalton Dietrich; Robert W Keane
Journal:  Glia       Date:  2011-12-07       Impact factor: 7.452

2.  A modified in vitro method to obtain pure astrocyte cultures induced from mouse hippocampal neural stem cells using clonal expansion.

Authors:  Wei Wang; Wei Shi; Hao Li
Journal:  Cell Mol Neurobiol       Date:  2011-12-15       Impact factor: 5.046

3.  CD36 is involved in astrocyte activation and astroglial scar formation.

Authors:  Yi Bao; Luye Qin; Eunhee Kim; Sangram Bhosle; Hengchang Guo; Maria Febbraio; Renee E Haskew-Layton; Rajiv Ratan; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-18       Impact factor: 6.200

Review 4.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

5.  Specific disruption of astrocytic Ca2+ signaling pathway in vivo by adeno-associated viral transduction.

Authors:  Y Xie; T Wang; G Y Sun; S Ding
Journal:  Neuroscience       Date:  2010-08-22       Impact factor: 3.590

6.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

7.  Dietary restriction enhances kainate-induced increase in NCAM while blocking the glial activation in adult rat brain.

Authors:  Sandeep Sharma; Gurcharan Kaur
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

Review 8.  Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury.

Authors:  Yunxiang Zhou; Anwen Shao; Yihan Yao; Sheng Tu; Yongchuan Deng; Jianmin Zhang
Journal:  Cell Commun Signal       Date:  2020-04-15       Impact factor: 5.712

9.  Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.

Authors:  Jung-Yu C Hsu; Lilly Y W Bourguignon; Christen M Adams; Karine Peyrollier; Haoqian Zhang; Thomas Fandel; Christine L Cun; Zena Werb; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

10.  Time-dependent effect of combination therapy with erythropoietin and granulocyte colony-stimulating factor in a mouse model of hypoxic-ischemic brain injury.

Authors:  Ji Hea Yu; Jung Hwa Seo; Jong Eun Lee; Ji Hoe Heo; Sung-Rae Cho
Journal:  Neurosci Bull       Date:  2014-01-16       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.